Lois Friedlander

1.0k total citations
26 papers, 851 citations indexed

About

Lois Friedlander is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Lois Friedlander has authored 26 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hepatology, 17 papers in Epidemiology and 4 papers in Rheumatology. Recurrent topics in Lois Friedlander's work include Hepatitis C virus research (19 papers), Liver Disease Diagnosis and Treatment (14 papers) and Hepatitis B Virus Studies (11 papers). Lois Friedlander is often cited by papers focused on Hepatitis C virus research (19 papers), Liver Disease Diagnosis and Treatment (14 papers) and Hepatitis B Virus Studies (11 papers). Lois Friedlander collaborates with scholars based in United States and Italy. Lois Friedlander's co-authors include David H. Van Thiel, S. Fagiuoli, Harlan I. Wright, Robert J. Kania, William Irish, Judith S. Gavaler, C. D. Cook, Paolo Caraceni, Alessandra Colantoni and Nicola De Maria and has published in prestigious journals such as Hepatology, PEDIATRICS and Journal of Hepatology.

In The Last Decade

Lois Friedlander

25 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lois Friedlander United States 14 522 517 128 89 78 26 851
A. Redaelli Italy 14 410 0.8× 398 0.8× 63 0.5× 38 0.4× 185 2.4× 24 707
A Taranta United States 12 179 0.3× 233 0.5× 30 0.2× 53 0.6× 131 1.7× 37 639
Takanobu Shigeta Japan 20 511 1.0× 210 0.4× 72 0.6× 18 0.2× 728 9.3× 74 1.0k
J. Miller United States 18 187 0.4× 139 0.3× 39 0.3× 69 0.8× 731 9.4× 101 1.1k
Marie‐Noëlle Hilleret France 15 657 1.3× 732 1.4× 36 0.3× 18 0.2× 118 1.5× 45 966
Bernard Ellero France 12 203 0.4× 162 0.3× 53 0.4× 15 0.2× 178 2.3× 42 441
Brigitte Zins France 8 114 0.2× 239 0.5× 21 0.2× 101 1.1× 68 0.9× 9 505
A Yussim Israel 14 120 0.2× 186 0.4× 54 0.4× 21 0.2× 241 3.1× 49 626
Naresh Shanmugam India 15 186 0.4× 120 0.2× 130 1.0× 17 0.2× 388 5.0× 72 615

Countries citing papers authored by Lois Friedlander

Since Specialization
Citations

This map shows the geographic impact of Lois Friedlander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lois Friedlander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lois Friedlander more than expected).

Fields of papers citing papers by Lois Friedlander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lois Friedlander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lois Friedlander. The network helps show where Lois Friedlander may publish in the future.

Co-authorship network of co-authors of Lois Friedlander

This figure shows the co-authorship network connecting the top 25 collaborators of Lois Friedlander. A scholar is included among the top collaborators of Lois Friedlander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lois Friedlander. Lois Friedlander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mascarenhas, Ranjan, et al.. (2004). Thalidomide Inhibits the Growth and Progression of Hepatic Epithelioid Hemangioendothelioma. Oncology. 67(5-6). 471–475. 55 indexed citations
2.
Nikolaidis, Lazaros A., et al.. (2004). Hepatitis C virus-associated pericardial effusion and tamponade in a liver transplant recipient.. PubMed. 20(7). 719–21. 5 indexed citations
3.
Thiel, David H. Van, et al.. (2002). Retreatment of High-Dose Interferon (5 MU Daily) Nonresponders with High-Dose IFN + Ribavirin. Digestive Diseases and Sciences. 47(9). 1932–1935.
4.
Maria, Nicola De, Alessandra Colantoni, Lois Friedlander, et al.. (2000). The Impact of Previous Hbv Infection on The Course of Chronic Hepatitis C. The American Journal of Gastroenterology. 95(12). 3529–3536. 87 indexed citations
5.
6.
Friedlander, Lois, et al.. (1999). Combined interferon, famciclovir and GM-CSF treatment of HBV infection in an individual with periarteritis nodosa.. PubMed. 46(28). 2529–31. 2 indexed citations
7.
Dh, Van Thiel, et al.. (1998). Treatment of chronic hepatitis C in individuals with pre-existing or confounding neuropsychiatric disease.. PubMed. 45(20). 328–30. 26 indexed citations
8.
Thiel, David H. Van, et al.. (1997). A preliminary experience with GM‐CSF plus interferon in patients with HBV and HCV resistant to interferon therapy. Journal of Viral Hepatitis. 4(s1). 101–106. 7 indexed citations
9.
Thiel, David H. Van, Lois Friedlander, Robert J. Kania, et al.. (1997). Retreatment of hepatitis C interferon non-responders with larger doses of interferon with and without phlebotomy.. PubMed. 43(12). 1557–61. 42 indexed citations
10.
Friedlander, Lois, et al.. (1996). New approach to HCV treatment. Digestive Diseases and Sciences. 41(8). 1678–1681. 19 indexed citations
11.
Thiel, David H. Van, Lois Friedlander, Paul Malloy, et al.. (1996). gamma-Glutamyl transpeptidase as a response predictor when using alpha-interferon to treat hepatitis C.. PubMed. 42(6). 888–92. 11 indexed citations
12.
Thiel, David H. Van, et al.. (1996). Interferon alpha treatment of chronic hepatitis C in patients with evidence for co-existent autoimmune dysregulation.. PubMed. 42(6). 900–6. 9 indexed citations
13.
Thiel, David H. Van, et al.. (1995). Treatment of Hepatitis C Virus in Elderly Persons With Interferon  . The Journals of Gerontology Series A. 50A(6). M330–M333. 12 indexed citations
14.
Gürakar, Ahmet, S. Fagiuoli, Hawazin Faruki, et al.. (1995). Utility of hepatitis C virus RNA determinations in hepatic tissue as an end point for interferon treatment of chronic hepatitis C. Hepatology. 22(4). 1109–1112. 11 indexed citations
15.
Gavaler, J. S., et al.. (1994). Treatment of putative non-A, non-B, non-C hepatitis with alpha interferon: a preliminary trial.. PubMed. 87(8). 364–8. 5 indexed citations
16.
Thiel, David H. Van, Lois Friedlander, S. Fagiuoli, et al.. (1994). Response to interferon α therapy is influenced by the iron content of the liver. Journal of Hepatology. 20(3). 410–415. 184 indexed citations
17.
Thiel, David H. Van, et al.. (1994). Intrahepatic mononuclear cell populations and MHC antigen expression in patients with chronic hepatitis B: Effect of interferon-α. Digestive Diseases and Sciences. 39(5). 970–976. 17 indexed citations
18.
Friedlander, Lois. (1994). Group Music Psychotherapy in an Inpatient Psychiatric Setting for Children: A Developmental Approach. Music Therapy Perspectives. 12(2). 92–97. 4 indexed citations
19.
Thiel, David H. Van, et al.. (1992). THE ASSOCIATION OF IgA DEFICIENCY BUT NOT IgG OR IgM DEFICIENCY WITH A REDUCED PATIENT AND GRAFT SURVIVAL FOLLOWING LIVER TRANSPLANTATION. Transplantation. 54(2). 269–272. 29 indexed citations
20.
Cook, C. D., et al.. (1958). STUDIES OF RESPIRATORY PHYSIOLOGY IN CHILDREN. PEDIATRICS. 22(1). 80–93. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Redaelli Breakdown of academic impact, for papers by A Taranta Breakdown of academic impact, for papers by Takanobu Shigeta Breakdown of academic impact, for papers by J. Miller Breakdown of academic impact, for papers by Marie‐Noëlle Hilleret Breakdown of academic impact, for papers by Bernard Ellero Breakdown of academic impact, for papers by Brigitte Zins Breakdown of academic impact, for papers by A Yussim Breakdown of academic impact, for papers by Naresh Shanmugam
Rankless by CCL
2026